MedTrace Logo

Clinical Trials

NCT07226986 | RECRUITING | PHASE1/PHASE2
123 participants

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2025-12-05
Completion:
2028-07-10
Conditions
  • PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Interventions
  • DRUG
  • RADIATION
No Results Yet
NCT07222930 | ENROLLING_BY_INVITATION
240 participants

Learning Amyloid and Tau Results

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-11
Start Date:
2026-02-17
Completion:
2029-06-30
Conditions
  • Alzheimer Disease
Interventions
  • OTHER
No Results Yet
NCT07185997 | RECRUITING | PHASE3
480 participants

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2025-12-17
Completion:
2029-02-28
Conditions
  • Non-Small-Cell Lung Cancer
  • Metastatic Non-Small-Cell Lung Cancer
  • Advanced Non-Small-Cell Lung Cancer
  • EGFR P-Loop and Alpha C-Helix Compressing
  • EGFR PACC
  • EGFR Uncommon Mutations
Interventions
  • DRUG
No Results Yet
NCT07182032 | WITHDRAWN | PHASE4
0 participants

Ketamine in Central Sensitization

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2026-02-01
Completion:
2028-06-30
Conditions
  • Endometriosis
  • Chronic Pelvic Pain
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page